Tanchou. Statistics of cancer. Lancet. 1843;40:649–50. doi:10.1016/S0140-6736(02)87094-5.
Ferlay J BF, Steliarova-Foucher E, Forman D. Cancer incidence in five continents, CI5plus: IARC CancerBase No. 9. 2014. http://ci5.iarc.fr. Accessed 19 Dec 2014.
American Cancer Society. Cancer facts and figures 2014. Atlanta, GA: American Cancer Society; 2014. http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf. Accessed 16 Dec 2014.
Google Scholar
Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, et al. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide: IARC CancerBase No. 11. 2013. http://globocan.iarc.fr. Accessed 29 Jul 2014.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403. doi:10.1016/j.ejca.2012.12.027.
CAS
PubMed
Google Scholar
Ly D, Forman D, Ferlay J, Brinton LA, Cook MB. An international comparison of male and female breast cancer incidence rates. Int J Cancer. 2013;132:1918–26. doi:10.1002/ijc.27841.
CAS
PubMed
Google Scholar
Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med. 2002;137:678–87. doi:10.7326/0003-4819-137-8-200210150-00013.
PubMed
Google Scholar
Scott-Conner CE, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126:775–80. Discussion 80–1.
CAS
PubMed
Google Scholar
Dabakuyo TS, Dialla O, Gentil J, Poillot ML, Roignot P, Cuisenier J, et al. Breast cancer in men in Cote d’Or (France): epidemiological characteristics, treatments and prognostic factors. Eur J Cancer Care. 2012;21:809–16. doi:10.1111/j.1365-2354.2012.01365.x.
CAS
Google Scholar
White J, Kearins O, Dodwell D, Horgan K, Hanby A, Speirs V. Male breast carcinoma: increased awareness needed. Breast Cancer Res. 2011;13:219.
PubMed
PubMed Central
Google Scholar
Hodgson NC, Button JH, Franceschi D, Moffat FL, Livingstone AS. Male breast cancer: is the incidence increasing? Ann Surg Oncol. 2004;11:751–5. doi:10.1245/aso.2004.01.001.
PubMed
Google Scholar
Contractor KB, Kaur K, Rodrigues GS, Kulkarni DM, Singhal H. Male breast cancer: is the scenario changing. World J Surg Oncol. 2008;6:58. doi:10.1186/1477-7819-6-58.
PubMed
PubMed Central
Google Scholar
Speirs V, Shaaban AM. The rising incidence of male breast cancer. Breast Cancer Res Treat. 2009;115:429–30. doi:10.1007/s10549-008-0053-y.
PubMed
Google Scholar
Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, et al. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst. 2014;106:djt465. doi:10.1093/jnci/djt465.
PubMed
PubMed Central
Google Scholar
Giordano S, Cohen D, Buzdar A, Perkins G, Hortobagyi G. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51–7.
PubMed
Google Scholar
Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat. 2004;83:77–86. doi:10.1023/B:BREA.0000010701.08825.2d.
PubMed
Google Scholar
SEER. Surveillance Epidemiology and End Results (SEER). Program Surveillance Research Program, Surveillance Systems Branch. 2015. NCI. www.seercancer.gov. Accessed 13 Dec 2014.
Shin JY, Kachnic LA, Hirsch AE. The impact of race in male breast cancer treatment and outcome in the United States: a population-based analysis of 4,279 patients. Int J Breast Cancer. 2014;2014:685842. doi:10.1155/2014/685842.
PubMed
PubMed Central
Google Scholar
Miao H, Verkooijen HM, Chia KS, Bouchardy C, Pukkala E, Laronningen S, et al. Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol. 2011;29:4381–6. doi:10.1200/jco.2011.36.8902.
PubMed
Google Scholar
Chavez-Macgregor M, Clarke CA, Lichtensztajn D, Hortobagyi GN, Giordano SH. Male breast cancer according to tumor subtype and race: a population-based study. Cancer. 2013;119:1611–7. doi:10.1002/cncr.27905.
PubMed
PubMed Central
Google Scholar
O’Malley CD, Prehn AW, Shema SJ, Glaser SL. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma. Cancer. 2002;94:2836–43. doi:10.1002/cncr.10521.
PubMed
Google Scholar
Sineshaw HM, Freedman RA, Ward EM, Flanders WD, Jemal A. Black/white disparities in receipt of treatment and survival among men with early-stage breast cancer. J Clin Oncol. 2015. Ahead of print. doi:10.1200/jco.2014.60.5584.
CRUK. Breast cancer incidence in males. 2014. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/incidence/uk-breast-cancer-incidence-statistics#source1. Accessed 28 Jan 2015.
John W. Nick Foundation. Sebastian, FL. 2015. https://www.malebreastcancer.org/. Accessed 14 May 2015.
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81. doi:10.1016/S0140-6736(14)60460-8.
PubMed
PubMed Central
Google Scholar
Roth J, Qiang X, Marban SL, Redelt H, Lowell BC. The obesity pandemic: where have we been and where are we going? Obes Res. 2004;12:88S–101. doi:10.1038/oby.2004.273.
PubMed
Google Scholar
Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378:804–14. doi:10.1016/s0140-6736(11)60813-1.
PubMed
Google Scholar
Annex A. World Health Organization. Obesity and overweight fact sheet. 2011. http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 20 Dec 2014.
Haidar YM, Cosman BC. Obesity epidemiology. Clin Colon Rectal Surg. 2011;24:205–10. doi:10.1055/s-0031-1295684.
PubMed
PubMed Central
Google Scholar
De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:11. doi:10.1155/2013/291546.
Google Scholar
AICR. World Cancer Research Fund. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC. 2nd Edition. http://discovery.ucl.ac.uk/4841/1/4841.pdf. 2007. Accessed 6 Jan 2015.
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311:806–14. doi:10.1001/jama.2014.732.
CAS
PubMed
PubMed Central
Google Scholar
White J, Kearins O, Dodwell D, Horgan K, Hanby AM, Speirs V. Male breast carcinoma: increased awareness needed. Breast Canc Res. 2011;13:219. doi:10.1186/bcr2930.
Google Scholar
Shaaban A, Ball G, Brannan R, Cserni G, Di Benedetto A, Dent J, et al. A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat. 2012;133:949–58. doi:10.1007/s10549-011-1856-9.
CAS
PubMed
Google Scholar
La Vecchia C, Negri E, Franceschi S, Talamini R, Bruzzi P, Palli D, et al. Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer. 1997;75:441–4.
PubMed
PubMed Central
Google Scholar
Trentham-Dietz A, Newcomb PA, Storer BE, Longnecker MP, Baron J, Greenberg ER, et al. Body size and risk of breast cancer. Am J Epidemiol. 1997;145:1011–9.
CAS
PubMed
Google Scholar
Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95:1218–26.
CAS
PubMed
Google Scholar
Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, et al. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:454–63. doi:10.1158/1055-9965.epi-10-0974.
CAS
PubMed
PubMed Central
Google Scholar
Monninkhof EM, van der Schouw YT, Peeters PH. Early age at menopause and breast cancer: are leaner women more protected? A prospective analysis of the Dutch DOM cohort. Breast Cancer Res Treat. 1999;55:285–91.
CAS
PubMed
Google Scholar
Scholz C, Andergassen U, Hepp P, Schindlbeck C, Friedl TW, Harbeck N, et al. Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer. Breast Cancer Res Treat. 2015. Ahead of print. doi:10.1007/s10549-015-3422-3.
Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893–907. doi:10.1158/1055-9965.epi-10-0437.
PubMed
Google Scholar
Anderson WF, Devesa SS. Breast carcinoma in men. Cancer. 2005;103:432–3. doi:10.1002/cncr.20797. Author reply 3.
PubMed
Google Scholar
Misra SP, Misra V, Dwivedi M. Cancer of the breast in a male cirrhotic: is there an association between the two? Am J Gastroenterol. 1996;91:380–2.
CAS
PubMed
Google Scholar
Guenel P, Cyr D, Sabroe S, Lynge E, Merletti F, Ahrens W, et al. Alcohol drinking may increase risk of breast cancer in men: a European population-based case–control study. Cancer Causes Contro. 2004;15:571–80. doi:10.1023/b:caco.0000036154.18162.43.
Google Scholar
Memon MA, Donohue JH. Male breast cancer. Br J Surg. 1997;84:433–5.
CAS
PubMed
Google Scholar
Alali L, Honarpisheh H, Shaaban A, Speirs V. Conditions of the male breast: gynaecomastia and male breast cancer (Review). Mol Med Rep. 2010;3:21–6. doi:10.3892/mmr_00000213.
CAS
PubMed
Google Scholar
Brinton LA, Richesson DA, Gierach GL, Lacey Jr JV, Park Y, Hollenbeck AR, et al. Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst. 2008;100:1477–81. doi:10.1093/jnci/djn329.
PubMed
PubMed Central
Google Scholar
Cook MB, Guenel P, Gapstur SM, van den Brandt PA, Michels KB, Casagrande JT, et al. Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium. Cancer Epidemiol Biomarkers Prev. 2015;24:520–31. doi:10.1158/1055-9965.epi-14-1009.
CAS
PubMed
Google Scholar
Bembo SA, Carlson HE. Gynecomastia: its features, and when and how to treat it. Cleve Clin J Med. 2004;71:511–7.
PubMed
Google Scholar
Rosen H, Webb ML, DiVasta AD, Greene AK, Weldon CB, Kozakewich H, et al. Adolescent gynecomastia: not only an obesity issue. Ann Plast Surg. 2010;64:688–90. doi:10.1097/SAP.0b013e3181dba827.
CAS
PubMed
Google Scholar
Ersoz H, Onde ME, Terekeci H, Kurtoglu S, Tor H. Causes of gynaecomastia in young adult males and factors associated with idiopathic gynaecomastia. Int J Androl. 2002;25:312–6.
PubMed
Google Scholar
Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A. Risk factors for male breast cancer – a case–control study from Scandinavia. Acta Oncologica (Stockholm, Sweden). 2001;40:467–71.
CAS
Google Scholar
Finkelstein JS, O’Dea LS, Whitcomb RW, Crowley Jr WF. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 1991;73:621–8. doi:10.1210/jcem-73-3-621.
CAS
PubMed
Google Scholar
Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley Jr WF. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab. 2000;85:3027–35. doi:10.1210/jcem.85.9.6795.
CAS
PubMed
Google Scholar
Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male. 2002;5:98–102.
CAS
PubMed
Google Scholar
Tchernof A, Mansour MF, Pelletier M, Boulet MM, Nadeau M, Luu-The V. Updated survey of the steroid-converting enzymes in human adipose tissues. J Steroid Biochem Mol Biol. 2015;147c:56–69. doi:10.1016/j.jsbmb.2014.11.011.
Google Scholar
Takagi K, Moriya T, Kurosumi M, Oka K, Miki Y, Ebata A, et al. Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma. Horm Cancer. 2013;4:1–11. doi:10.1007/s12672-012-0126-6.
CAS
PubMed
Google Scholar
Speirs V, Green AR, White MC. A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples. Int J Cancer. 1996;66:551–6. doi:10.1002/(sici)1097-0215(19960516)66:4<551::aid-ijc21>3.0.co;2-9.
CAS
PubMed
Google Scholar
Speirs V, Adams EF, White MC. The anti-estrogen tamoxifen blocks the stimulatory effects of interleukin-6 on 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells. J Steroid Biochem Mol Biol. 1993;46:605–11.
CAS
PubMed
Google Scholar
Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer. 2007;14:189–206. doi:10.1677/erc-06-0068.
CAS
PubMed
Google Scholar
Schaffler A, Scholmerich J, Buechler C. Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat Clin Pract Endocrinol Metab. 2007;3:345–54. doi:10.1038/ncpendmet0456.
PubMed
Google Scholar
Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci. 2011;1229:45–52. doi:10.1111/j.1749-6632.2011.06096.x.
CAS
PubMed
Google Scholar
Wang YY, Lehuede C, Laurent V, Dirat B, Dauvillier S, Bochet L, et al. Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer. Cancer Lett. 2012;324:142–51. doi:10.1016/j.canlet.2012.05.019.
CAS
PubMed
Google Scholar
Cleary MP. Impact of obesity on development and progression of mammary tumors in preclinical models of breast cancer. J Mammary Gland Biol Neoplasia. 2013;18:333–43. doi:10.1007/s10911-013-9300-x.
PubMed
PubMed Central
Google Scholar
Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, et al. Prediagnostic sex steroid hormones in relation to male breast cancer risk. J Clin Oncol. 2015. Ahead of print. doi:10.1200/jco.2014.59.1602.
Schneider G, Kirschner MA, Berkowitz R, Ertel NH. Increased estrogen production in obese men. J Clin Endocrinol Metab. 1979;48:633–8. doi:10.1210/jcem-48-4-633.
CAS
PubMed
Google Scholar
Kley HK, Edelmann P, Kruskemper HL. Relationship of plasma sex hormones to different parameters of obesity in male subjects. Metabolism. 1980;29:1041–5.
CAS
PubMed
Google Scholar
Strain GW, Zumoff B, Kream J, Strain JJ, Deucher R, Rosenfeld RS, et al. Mild hypogonadotropic hypogonadism in obese men. Metabolism. 1982;31:871–5.
CAS
PubMed
Google Scholar
Fui MN, Dupuis P, Grossmann M. Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 2014;16:223–31. doi:10.4103/1008-682x.122365.
CAS
PubMed
PubMed Central
Google Scholar
Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf). 2006;65:125–31. doi:10.1111/j.1365-2265.2006.02560.x.
CAS
PubMed
Google Scholar
Rohrmann S, Shiels MS, Lopez DS, Rifai N, Nelson WG, Kanarek N, et al. Body fatness and sex steroid hormone concentrations in US men: results from NHANES III. Cancer Causes Contro. 2011;22:1141–51. doi:10.1007/s10552-011-9790-z.
Google Scholar
Ahn J, Schatzkin A, Lacey Jr JV, Albanes D, Ballard-Barbash R, Adams KF, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med. 2007;167:2091–102. doi:10.1001/archinte.167.19.2091.
PubMed
Google Scholar
Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Doosti IA. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One. 2012;7:e51446. doi:10.1371/journal.pone.0051446.
CAS
PubMed
PubMed Central
Google Scholar
Hartz AJ, He T. Cohort study of risk factors for breast cancer in post menopausal women. Epidemiol Health. 2013;35:e2013003. doi:10.4178/epih/e2013003.
PubMed
PubMed Central
Google Scholar
Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367:595–604. doi:10.1016/s0140-6736(06)68226-3.
PubMed
Google Scholar
Greif JM, Pezzi CM, Klimberg VS, Bailey L, Zuraek M. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base. Ann Surg Oncol. 2012;19:3199–204. doi:10.1245/s10434-012-2479-z.
PubMed
Google Scholar
El-Tamer MB, Komenaka IK, Troxel A, Li H, Joseph KA, Ditkoff BA, et al. Men with breast cancer have better disease-specific survival than women. Arch Surg. 2004;139:1079–82. doi:10.1001/archsurg.139.10.1079.
PubMed
Google Scholar
Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Body mass and stage of breast cancer at diagnosis. Int J Cancer. 2002;98:279–83.
CAS
PubMed
Google Scholar
Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B. Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat. 2008;111:329–42. doi:10.1007/s10549-007-9785-3.
PubMed
Google Scholar
Haakinson DJ, Leeds SG, Dueck AC, Gray RJ, Wasif N, Stucky CC, et al. The impact of obesity on breast cancer: a retrospective review. Ann Surg Oncol. 2012;19:3012–8. doi:10.1245/s10434-012-2320-8.
PubMed
Google Scholar
Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Patient delay and stage of diagnosis among breast cancer patients in Germany – a population based study. Br J Cancer. 2002;86:1034–40. doi:10.1038/sj.bjc.6600209.
CAS
PubMed
PubMed Central
Google Scholar
Deglise C, Bouchardy C, Burri M, Usel M, Neyroud-Caspar I, Vlastos G, et al. Impact of obesity on diagnosis and treatment of breast cancer. Breast Cancer Res Treat. 2010;120:185–93. doi:10.1007/s10549-009-0459-1.
PubMed
Google Scholar
Jordan VC. Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer. Endocr Relat Cancer. 2014;21:R235–46. doi:10.1530/erc-14-0092.
CAS
PubMed
PubMed Central
Google Scholar
Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer. 1992;65:252–4.
CAS
PubMed
PubMed Central
Google Scholar
Baojiang L, Tingting L, Gang L, Li Z. Male breast cancer: a retrospective study comparing survival with female breast cancer. Oncol Lett. 2012;4:642–6. doi:10.3892/ol.2012.809.
PubMed
PubMed Central
Google Scholar
Zagouri F, Sergentanis TN, Chrysikos D, Dimopoulos MA, Psaltopoulou T. Fulvestrant and male breast cancer: a pooled analysis. Breast Cancer Res Treat. 2015;149:269–75. doi:10.1007/s10549-014-3240-z.
CAS
PubMed
Google Scholar
Wenhui Z, Shuo L, Dabei T, Ying P, Zhipeng W, Lei Z, et al. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment. Eur J Endocrinol. 2014;171:527–33. doi:10.1530/eje-14-0278.
PubMed
Google Scholar
Maugeri-Sacca M, Barba M, Vici P, Pizzuti L, Sergi D, De Maria R, et al. Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations. Breast Cancer Res Treat. 2014;147:227–35. doi:10.1007/s10549-014-3087-3.
CAS
PubMed
Google Scholar
Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet. 2002;359:2131–9.
CAS
PubMed
Google Scholar
Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer. 2003;98:1802–10. doi:10.1002/cncr.11745.
CAS
PubMed
Google Scholar
Johansson I, Killander F, Linderholm B, Hedenfalk I. Molecular profiling of male breast cancer – Lost in translation? Int J Biochem Cell Biol. 2014;53:526–35. doi:10.1016/j.biocel.2014.05.007.
CAS
PubMed
Google Scholar
Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, et al. Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol. 2012;25:398–404. doi:10.1038/modpathol.2011.174.
CAS
PubMed
Google Scholar
Callari M, Cappelletti V, De Cecco L, Musella V, Miodini P, Veneroni S, et al. Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. Breast Cancer Res Treat. 2011;127:601–10. doi:10.1007/s10549-010-1015-8.
CAS
PubMed
Google Scholar
Johansson I, Nilsson C, Berglund P, Strand C, Jonsson G, Staaf J, et al. High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer. Breast Cancer Res Treat. 2011;129:747–60. doi:10.1007/s10549-010-1262-8.
PubMed
Google Scholar
Pinto R, De Summa S, Danza K, Popescu O, Paradiso A, Micale L, et al. MicroRNA expression profiling in male and female familial breast cancer. Br J Cancer. 2014;111:2361–8. doi:10.1038/bjc.2014.535.
CAS
PubMed
PubMed Central
Google Scholar
Eggemann H, Ignatov A, Smith BJ, Altmann U, von Minckwitz G, Rohl FW, et al. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast Cancer Res Treat. 2013;137:465–70. doi:10.1007/s10549-012-2355-3.
CAS
PubMed
Google Scholar
Bhatnagar AS, Müller P, Schenkel L, Trunet PF, Beh I, Schieweck K. Inhibition of estrogen biosynthesis and its consequences on gonadotrophin secretion in the male. J Steroid Biochem Mol Biol. 1992;41:437–43. doi:10.1016/0960-0760(92)90369-T.
CAS
PubMed
Google Scholar
Trunet PF, Mueller P, Bhatnagar AS, Dickes I, Monnet G, White G. Open dose-finding study of a new potent and selective nonsteroidal aromatase inhibitor, CGS 20 267, in healthy male subjects. J Clin Endocrinol Metab. 1993;77:319–23. doi:10.1210/jcem.77.2.8345034.
CAS
PubMed
Google Scholar
Mauras N, O’Brien KO, Klein KO, Hayes V. Estrogen suppression in males: metabolic effects. J Clin Endocrinol Metab. 2000;85:2370–7. doi:10.1210/jcem.85.7.6676.
CAS
PubMed
Google Scholar
Doyen J, Italiano A, Largillier R, Ferrero JM, Fontana X, Thyss A. Aromatase inhibition in male breast cancer patients: biological and clinical implications. Ann Oncol. 2010;21:1243–5. doi:10.1093/annonc/mdp450.
CAS
PubMed
Google Scholar
Wang L, Ellsworth KA, Moon I, Pelleymounter LL, Eckloff BW, Martin YN, et al. Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors. Cancer Res. 2010;70:319–28. doi:10.1158/0008-5472.can-09-3224.
CAS
PubMed
PubMed Central
Google Scholar
Flote VG, Furberg A, McTiernan A, Frydenberg H, Ursin G, Iversen A, et al. Gene variations in oestrogen pathways, CYP19A1, daily 17ss-estradiol and mammographic density phenotypes in premenopausal women. Breast Canc Res. 2014;16:499. doi:10.1186/s13058-014-0499-2.
Google Scholar
Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med. 2007;13:1185–92. doi:10.1038/nm1641.
CAS
PubMed
Google Scholar
Cali JJ, Russell DW. Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J Biol Chem. 1991;266:7774–8.
CAS
PubMed
Google Scholar
DuSell CD, Umetani M, Shaul PW, Mangelsdorf DJ, McDonnell DP. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol (Baltimore, Md). 2008;22:65–77. doi:10.1210/me.2007-0383.
CAS
Google Scholar
Wu Q, Ishikawa T, Sirianni R, Tang H, McDonald JG, Yuhanna IS, et al. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Rep. 2013;5:637–45. doi:10.1016/j.celrep.2013.10.006.
CAS
PubMed
PubMed Central
Google Scholar
Burkard I, von Eckardstein A, Waeber G, Vollenweider P, Rentsch KM. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. Atherosclerosis. 2007;194:71–8. doi:10.1016/j.atherosclerosis.2006.09.026.
PubMed
Google Scholar
Popkin BM, Adair LS, Ng SW. The global nutrition transition: the pandemic of obesity in developing countries. Nutr Rev. 2012;70:3–21. doi:10.1111/j.1753-4887.2011.00456.x.
PubMed
PubMed Central
Google Scholar
Darbre PD. Aluminium, antiperspirants and breast cancer. J Inorg Biochem. 2005;99:1912–9. doi:10.1016/j.jinorgbio.2005.06.001.
CAS
PubMed
Google Scholar
Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS. Concentrations of parabens in human breast tumours. J Appl Toxicol. 2004;24:5–13. doi:10.1002/jat.958.
CAS
PubMed
Google Scholar
Dieterich M, Stubert J, Reimer T, Erickson N, Berling A. Influence of lifestyle factors on breast cancer risk. Breast Care (Basel, Switzerland). 2014;9:407–14. doi:10.1159/000369571.
Google Scholar
Rodrigues-Peres RM, Cadore S, Febraio S, Heinrich JK, Serra KP, Derchain SF, et al. Aluminum concentrations in central and peripheral areas of malignant breast lesions do not differ from those in normal breast tissues. BMC Cancer. 2013;13:104. doi:10.1186/1471-2407-13-104.
CAS
PubMed
PubMed Central
Google Scholar
Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM, et al. Difference in association of obesity with prostate cancer risk between US African American and non-Hispanic white men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA Oncol. 2015. Ahead of print. doi:10.1001/jamaoncol.2015.0513.
Stanik S, Dornfeld LP, Maxwell MH, Viosca SP, Korenman SG. The effect of weight loss on reproductive hormones in obese men. J Clin Endocrinol Metab. 1981;53:828–32. doi:10.1210/jcem-53-4-828.
CAS
PubMed
Google Scholar
Pellitero S, Olaizola I, Alastrue A, Martinez E, Granada ML, Balibrea JM, et al. Hypogonadotropic hypogonadism in morbidly obese males is reversed after bariatric surgery. Obes Surg. 2012;22:1835–42. doi:10.1007/s11695-012-0734-9.
PubMed
Google Scholar
Blouin K, Veilleux A, Luu-The V, Tchernof A. Androgen metabolism in adipose tissue: recent advances. Mol Cell Endocrinol. 2009;301:97–103. doi:10.1016/j.mce.2008.10.035.
CAS
PubMed
Google Scholar
Tomlinson JW, Stewart PM. The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue. Horm Metab Res. 2002;34:746–51.
CAS
PubMed
Google Scholar